HC Wainwright Initiates Coverage on Heron Therapeutics (NASDAQ:HRTX)
HC Wainwright initiated coverage on shares of Heron Therapeutics (NASDAQ:HRTX – Free Report) in a report published on Monday, Marketbeat Ratings reports. The brokerage issued a buy rating and a $6.00 price target on the biotechnology company’s stock. A number of other research firms have also weighed in on HRTX. Needham & Company LLC restated […]
HC Wainwright initiated coverage on shares of Heron Therapeutics (NASDAQ:HRTX – Free Report) in a report published on Monday, Marketbeat Ratings reports. The brokerage issued a buy rating and a $6.00 price target on the biotechnology company’s stock. A number of other research firms have also weighed in on HRTX. Needham & Company LLC restated […]
